Skip to content
Clinical Trials – home
Research site

University Of Turku

Finland P. O. Box 52, 20521 Turku, Finland

  • 2 trials recruiting
  • Progressive multiple sclerosis · Acute lymphocytic leukaemia
  • Adults and children

About Specializations

University Of Turku in Turku, Finland specialises in clinical trials of conditions such as Progressive multiple sclerosis, Acute lymphocytic leukaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms and Immune System Diseases

Research at the University Of Turku focuses on acute lymphoblastic leukemia in infants, with studies aimed at improving survival outcomes and strengthening treatment effectiveness for newly diagnosed cases.

  • Evaluating new approaches for infant acute lymphoblastic leukemia
  • Measuring whether care can improve event-free survival
  • Comparing results with earlier treatment experience

This area reflects a strong interest in pediatric cancer research, combining clinical care with efforts to refine treatment strategies for rare and high-risk blood cancers.

Nervous System Diseases

Clinical trials in Clinical Neurosciences examine progressive multiple sclerosis, with the goal of better understanding and reducing ongoing inflammation in the brain and white matter.

  • Studying progressive multiple sclerosis
  • Assessing changes in brain inflammation markers
  • Exploring whether treatment can improve disease control

At University Of Turku, this work supports research into new ways to monitor and potentially ease neuroinflammatory activity in chronic neurological disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
P. O. Box 5220521 TurkuFinland
Recruiting now
2 trials
Conditions studied
2

More sites in TurkuFinland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Istradefylline
  • Sponsor:University Of Turku
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Asparaginase
  • Sponsor:Princess Maxima Center For Pediatric Oncology
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.